Gemtuzumab Ozogamicin

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (gem-TOO-zoo-mab OH-zoh-ga-MIH-sin )

This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Mylotarg
FDA Approved
No

Use in Cancer

As of June 21, 2010, gemtuzumab ozogamicin is no longer available to new patients, due to concerns about whether the drug is safe and effective. Patients who are already being treated with this drug may continue their treatment, depending on their doctor's advice. To learn more, see Gemtuzumab Ozogamicin Voluntarily Withdrawn from U.S. Markets.

Gemtuzumab ozogamicin was originally approved to treat:

Gemtuzumab ozogamicin continues to be studied in the treatment of leukemia and other conditions.

More About Gemtuzumab Ozogamicin

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Targeted Cancer Therapies - Information about the use of this drug to treat cancer.

Clinical Trials Accepting Patients

Find Clinical Trials for Gemtuzumab Ozogamicin - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: January 25, 2007
  • Updated: November 23, 2016